Skip to main content
. 2023 Nov 7;6(1):148–159. doi: 10.1159/000534473

Fig. 4.

Fig. 4.

a Average “CBD Equivalent” plasma concentration for rats administered CBD via oral UltraShear nanoemulsion versus via IV injection, including metabolites adjusted for MW differences versus CBD. b Comparison of average oral/IV total absorption of “CBD equivalents” versus bioavailability for “CBD only” after first-pass metabolism.